Hubei Xunda Pharmaceutical Co., Ltd. – FDA Inspection, May 26, 2017

Record Details

This FDA Inspection record concerns Hubei Xunda Pharmaceutical Co., Ltd., with an inspection on May 26, 2017, issued by the Center for Drug Evaluation and Research, covering drugs.

Company: Hubei Xunda Pharmaceutical Co., Ltd.
Inspection Date: May 26, 2017
Product Type: Drugs
Office: Center for Drug Evaluation and Research
Person: Arsen Karapetyan

View Company Profile

ID · e9387c4f-30e0-4170-a983-42d3ad8e3504

Inspection Facts

Voluntary Action Indicated (VAI)

Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.

Inspection number: 1015952
FDA center: Human Drugs
Project area: Drug Quality Assurance
Outcome: Form 483 issued

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Hubei Xunda Pharmaceutical Co., Ltd.

FDA Inspection

Hubei Xunda Pharmaceutical Co., Ltd.May 26, 2017